Skip to main content

Vertex Pharmaceutic(VRTX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low302.87
Day High315.00
Open:305.38
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

Download Premium PDFRefinitiv. Trademark. Data is Just the Beginning.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Download Premium PDFStockCalc

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Download Premium PDFValueEngine

Press & news

Latest News

More Stories
Nasdaq Bear Market: 2 Growth Stocks to Buy That Keep Bucking the Trend
Motley Fool - Sat Mar 25, 4:41AM CDT
Motley Fool
Sat Mar 25, 4:41AM CDT
These red-hot stocks keep climbing despite the bear market.
This Is My Highest-Conviction Stock to Own in 2023 and Beyond
Motley Fool - Thu Mar 23, 6:45AM CDT
Motley Fool
Thu Mar 23, 6:45AM CDT
This company has already delivered market-beating returns, but it's not too late to get in.
Got $3,000? 3 Growth Stocks to Double Up on Right Now
Motley Fool - Thu Mar 23, 4:50AM CDT
Motley Fool
Thu Mar 23, 4:50AM CDT
The great prospects for these stocks make them worthy of bigger bets.

Latest Articles

number cruncher
Ten U.S. companies with a strong competitive advantage and solid earnings momentum
number cruncher
Twenty U.S. growth stocks with high reinvestment rates and earnings momentum
Deals, data buzz could help biotech shares exit Wall Street’s ‘no man’s land’
number cruncher
These 10 U.S. large-cap stocks demonstrate consistent, solid profitability
number cruncher
Strong cash flow for tumultuous times: Check out these 14 S&P 500 stocks
number cruncher
These S&P 500 stocks see their sales grow despite difficult times
top links
Gen Z spending habits pose risks for auto, meat and alcohol industries
top links
Top U.S. growth stock picks for any economic environment: Goldman Sachs
number cruncher
Twenty U.S. stocks with similar fundamentals to the S&P 500′s ‘Big Five’
top links
Bank of America’s top ten U.S. stock picks for growth and value investors
top links
BofA’s top 10 U.S. stock picks for growth and value investors
number cruncher
Ten U.S. stocks with the financial flexibility to withstand a second downturn

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.